FEMORAL -INTERNAL ILIAC BYPASS IN AORTOILIAC ANEURYSMS ENDOVASCULAR REPAIR
. The stentgraft must be extended into the external iliac artery. The internal iliac artery is excluded from the direct blood fl ow and its origin must be occluded to prevent retrograde endoleak. Artifi cial occlusion of to this time open both internal iliac arteries may be tolerated, but with concomitant exclusion of inferior mesenteric artery and lumbal arteries by aortic stentgraft the risk of severe ischaemia can be signifi cant [3] [4] [5] [6] [7] . Concomitant anatomical factors, however, are of importance. The basic condition is patend superior mesenteric artery 3 .
METHOD
From April 1996 to April 2004 we treated endovascularly 140 infrarenal AAA with Czech made ELLA stentgraft system [8] [9] [10] [11] . In 25 patients the aneurysmal dilatation of the common iliac artery necessitated extension of the device across the internal iliac artery origin. In 12 of these patients (AAA of type II C/2 ) the internal iliac artery origin was overstented and then occluded on both sides (Fig. 1, 2) . Severe ischemic complications (colorectal and spinal cord ischemia) did not occur, but the fi rst 6 patients had indefi nite pelvic discomfort and hip-buttock claudications.
In the last 6 patients one of the two ligated internal iliac arteries was transsected and anastomosed using ePTFE prosthesis interposition with common femoral artery from groin access (Fig. 3, 4 ).
There were no procedure related complications. All the bypasses are primarily patent to date and the patients are ischemic symptom free (Fig. 5) .
CONCLUSION
From our point of view aortoiliac aneurysms (type II C according to Schumacher -type D,E to EUROS-TAR) are not contraindications for EVAR.
One patent internal iliac artery with direct blood fl ow (in the type II C/1 of AAA) is quite suffi cient.
In patients where both internal iliac arteries have to be ligated at their origin (type II C/2 of AAA) we recommend unilateral femoral-internal iliac bypass from groin access as a simple, safe and eff ective method to prevent severe ischemic complications and to remove ischemic discomfort.
